These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 25155802)

  • 61. Ramucirumab and Paclitaxel Administered Every 2 Weeks (mRAINBOW Regimen) in Advanced Gastroesophageal Adenocarcinoma.
    Rogers JE; Xiao L; Amlashi FG; Elimova E; Blum Murphy MA; Sanders E; Shanbhag N; Thomas I; Ajani JA
    Oncology; 2019; 96(5):252-258. PubMed ID: 30893708
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Bortezomib, paclitaxel, and carboplatin as a first-line regimen for patients with metastatic esophageal, gastric, and gastroesophageal cancer: phase II results from the North Central Cancer Treatment Group (N044B).
    Jatoi A; Dakhil SR; Foster NR; Ma C; Rowland KM; Moore DF; Jaslowski AJ; Thomas SP; Hauge MD; Flynn PJ; Stella PJ; Alberts SR
    J Thorac Oncol; 2008 May; 3(5):516-20. PubMed ID: 18449005
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A phase I and pharmacokinetic study of weekly paclitaxel and carboplatin in patients with metastatic esophageal cancer.
    Polee MB; Sparreboom A; Eskens FA; Hoekstra R; van de Schaaf J; Verweij J; Stoter G; van der Gaast A
    Clin Cancer Res; 2004 Mar; 10(6):1928-34. PubMed ID: 15041708
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Combination chemotherapy with paclitaxel and oxaliplatin as first-line treatment in patients with advanced gastric cancer.
    Lan YQ; Kong LJ; Lin XY; Xu Q; Gao XY; Wu RP; Wang XL; Zhong DT
    Cancer Chemother Pharmacol; 2018 Jun; 81(6):1007-1015. PubMed ID: 29619507
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A retrospective study of paclitaxel combining nedaplatin chemotherapy for esophageal cancer.
    Du J; Hu C; Zhang Y; Hu B; Wang F; Zhang Y
    Anticancer Drugs; 2015 Jan; 26(1):101-5. PubMed ID: 25222530
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Phase II trial of nanoparticle albumin-bound paclitaxel as second-line chemotherapy for unresectable or recurrent gastric cancer.
    Sasaki Y; Nishina T; Yasui H; Goto M; Muro K; Tsuji A; Koizumi W; Toh Y; Hara T; Miyata Y
    Cancer Sci; 2014 Jul; 105(7):812-7. PubMed ID: 24716542
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A phase II study of paclitaxel and nedaplatin as front-line chemotherapy in Chinese patients with metastatic esophageal squamous cell carcinoma.
    He YF; Ji CS; Hu B; Fan PS; Hu CL; Jiang FS; Chen J; Zhu L; Yao YW; Wang W
    World J Gastroenterol; 2013 Sep; 19(35):5910-6. PubMed ID: 24124338
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clinical outcomes of definitive chemoradiotherapy using carboplatin and paclitaxel in esophageal cancer.
    van Ruler MA; Peters FP; Slingerland M; Fiocco M; Grootenboers DA; Vulink AJ; Marijnen CA; Neelis KJ
    Dis Esophagus; 2017 Apr; 30(4):1-9. PubMed ID: 28375477
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Phase I/Ib study of crenolanib with ramucirumab and paclitaxel as second-line therapy for advanced esophagogastric adenocarcinoma.
    Moy RH; Greally M; Chou JF; Li J; Desai AM; Chalasani SB; Won E; Kelsen DP; Ilson DH; Janjigian YY; Capanu M; Ku GY
    Cancer Chemother Pharmacol; 2022 Feb; 89(2):255-265. PubMed ID: 35066693
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effectiveness of carboplatin and paclitaxel as first- and second-line treatment in 61 patients with metastatic melanoma.
    Pflugfelder A; Eigentler TK; Keim U; Weide B; Leiter U; Ikenberg K; Berneburg M; Garbe C
    PLoS One; 2011 Feb; 6(2):e16882. PubMed ID: 21359173
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A phase II open-label study of DHA-paclitaxel (Taxoprexin) by 2-h intravenous infusion in previously untreated patients with locally advanced or metastatic gastric or oesophageal adenocarcinoma.
    Jones RJ; Hawkins RE; Eatock MM; Ferry DR; Eskens FA; Wilke H; Evans TR
    Cancer Chemother Pharmacol; 2008 Mar; 61(3):435-41. PubMed ID: 17440725
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Outcomes of Ramucirumab Plus Paclitaxel Among Patients With Previously Treated Metastatic Gastric/Lower Esophageal Cancer: A Real-world Study.
    Abdel-Rahman O; Mulder K; Easaw J
    Am J Clin Oncol; 2021 Apr; 44(4):158-161. PubMed ID: 33625121
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Paclitaxel, carboplatin, and oral etoposide in advanced gastric adenocarcinoma: association with severe myelotoxicity.
    Bar-Sela G; Tsalic M; Gaitini D; Steiner M; Haim N
    Med Oncol; 2003; 20(3):291-4. PubMed ID: 14514979
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Chemoradiation in elderly esophageal cancer patients: rationale and design of a phase I/II multicenter study (OSAGE).
    Servagi-Vernat S; Créhange G; Bonnetain F; Mertens C; Brain E; Bosset JF
    BMC Cancer; 2017 Jul; 17(1):483. PubMed ID: 28705182
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Efficacy of Sequential Ipilimumab Monotherapy versus Best Supportive Care for Unresectable Locally Advanced/Metastatic Gastric or Gastroesophageal Junction Cancer.
    Bang YJ; Cho JY; Kim YH; Kim JW; Di Bartolomeo M; Ajani JA; Yamaguchi K; Balogh A; Sanchez T; Moehler M
    Clin Cancer Res; 2017 Oct; 23(19):5671-5678. PubMed ID: 28655793
    [No Abstract]   [Full Text] [Related]  

  • 76. A clinical trial protocol paper discussing the BRIGHTER study.
    Sonbol MB; Bekaii-Saab T
    Future Oncol; 2018 Apr; 14(10):901-906. PubMed ID: 29297698
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Association between neutropenia and response to ramucirumab and paclitaxel in patients with metastatic gastric cancer.
    Roviello G; Conca R; D'Angelo A; Multari AG; Paganini G; Chiriacò G; Petrioli R; Corona SP; Rosellini P; Aieta M
    Anticancer Drugs; 2020 Jul; 31(6):632-636. PubMed ID: 32011363
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The safety and efficacy of ramucirumab in combination with paclitaxel for the treatment of advanced gastric or gastro-esophageal junction adenocarcinoma.
    Garrido M
    Expert Rev Anticancer Ther; 2016 Oct; 16(10):1005-10. PubMed ID: 27582051
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clozapine and concomitant chemotherapy in a patient with schizophrenia and new onset esophageal cancer.
    Monga V; Broucek M; Amani M; Ramaswamy S
    Psychooncology; 2015 Aug; 24(8):971-2. PubMed ID: 25644505
    [No Abstract]   [Full Text] [Related]  

  • 80. Palliative Radiotherapy in the Presence of Well-Controlled Metastatic Disease after Initial Chemotherapy May Prolong Survival in Patients with Metastatic Esophageal and Gastric Cancer.
    Hingorani M; Dixit S; Johnson M; Plested V; Alty K; Colley P; Beavis AW; Roy R; Maraveyas A
    Cancer Res Treat; 2015 Oct; 47(4):706-17. PubMed ID: 25687854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.